EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Cerebrovascular Events in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation: A Pooled Patient‐Level Study

Astrid C van Nieuwkerk iD, Hugo M Aarts iD, Kimberley I Hemelrijk iD, Cristobal Urbano Carrillo iD, Didier Tchétché, Fabio S de Brito, Marco Barbanti iD, Ran Kornowski iD, Azeem Latib iD, Augusto D'Onofrio iD, Flavio Ribichini iD, Sergio García-Blas iD und 12 weitere

Journal of the American Heart Association · 2024

DOI: 10.1161/jaha.123.032901 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Astrid C van Nieuwkerk und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology Amsterdam UMC, University of Amsterdam, Amsterdam Cardiovascular Sciences Amsterdam the Netherlands. Hauptthemen laut MEDLINE: Aortic Valve Stenosis, Transcatheter Aortic Valve Replacement. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Cerebrovascular events remain one of the most devastating complications of transcatheter aortic valve implantation (TAVI). Data from real‐world contemporary cohorts on longitudinal trends and outcomes remain limited. The aim of this study was to assess incidence, temporal trends, predictors, and outcomes of cerebrovascular events following transfemoral TAVI. Methods and Results The CENTER2 (Cerebrovascular Events in Patients Undergoing Transcatheter Aortic Valve Implantation With Balloon‐Expandable Valves Versus Self‐Expandable Valves 2) study includes patients undergoing TAVI between 2007 and 2022. The database contains pooled patient‐level data from 10 clinical studies. A total of 24 305 patients underwent transfemoral TAVI (mean age 81.5±6.7 years, 56% women, median Society of Thoracic Surgeon Predicted Risk of Mortality 4.9% [3.1%–8.5%]). Of these patients, 2.2% (n=534) experienced stroke in the first 30 days after TAVI, and 40 (0.4%) had a transient ischemic attack. Stroke rates remained stable during the treatment period (2007–2010: 2.1%, 2011–2014: 2.5%, 2015–2018: 2.1%, 2019–2022: 2.1%; P trend =0.28). Moreover, 30‐day cerebrovascular event rates were similar across Society of Thoracic Surgeon Predicted Risk of Mortality risk categories: 2.1% in low‐risk, 2.6% in intermediate‐risk, and 2.5% in high‐risk patients ( P =0.21). Mortality was higher in patients with 30‐day stroke than without at 30 days (20.3% versus 4.7%; odds ratio, 5.1 [95% CI, 4.1–6.5]; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic Valve StenosisTranscatheter Aortic Valve ReplacementAgedAged, 80 and overFemaleHumansMaleAortic ValveFemoral ArteryIncidenceIschemic Attack, TransientPostoperative ComplicationsRisk AssessmentRisk FactorsStrokeTime FactorsTreatment Outcome

Stichwörter der Autor:innen

aortic valve stenosismortalitystroketranscatheter aortic valve replacement

Autor:innen und Institutionen

  • Department of Cardiology Amsterdam UMC, University of Amsterdam, Amsterdam Cardiovascular Sciences Amsterdam the Netherlands.
  • Hospital Regional Universitario de Málaga Malaga Spain.
  • Clinique Pasteur Toulouse France.
  • Heart Institute, University of São Paulo Medical School São Paulo Brazil.
  • Università degli Studi di Enna "Kore" Enna Italy.
  • Cardiology Department Rabin Medical Center Petach Tikva Israel.

ORCID-Profile: Astrid C van Nieuwkerk, Hugo M Aarts, Kimberley I Hemelrijk, Cristobal Urbano Carrillo, Marco Barbanti, Ran Kornowski, Azeem Latib, Augusto D'Onofrio, Flavio Ribichini, Sergio García-Blas, Alexandre Abizaid, Samantha Sartori, Paola D'Errigo, Giuseppe Tarantini, Mattia Lunardi, Katia Orvin, Matteo Pagnesi, Felipe Navarro, George Dangas, Roxana Mehran, Ronak Delewi

Zitieren

APA

van Nieuwkerk, A. C., Aarts, H. M., Hemelrijk, K. I., Urbano Carrillo, C., Tchétché, D., de Brito, F. S., Barbanti, M., Kornowski, R., Latib, A., D'Onofrio, A., Ribichini, F., García-Blas, S., Dumonteil, N., Abizaid, A., Sartori, S., D'Errigo, P., Tarantini, G., Lunardi, M., Orvin, K., …, & Delewi, R. (2024). Cerebrovascular Events in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation: A Pooled Patient‐Level Study. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.032901

Vancouver

van Nieuwkerk AC, Aarts HM, Hemelrijk KI, Urbano Carrillo C, Tchétché D, de Brito FS, et al. Cerebrovascular Events in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation: A Pooled Patient‐Level Study. Journal of the American Heart Association. 2024. doi:10.1161/jaha.123.032901

BibTeX
@article{vanNieuwkerk2024,
  author = {van Nieuwkerk, Astrid C and Aarts, Hugo M and Hemelrijk, Kimberley I and Urbano Carrillo, Cristobal and Tchétché, Didier and de Brito, Fabio S and Barbanti, Marco and Kornowski, Ran and Latib, Azeem and D'Onofrio, Augusto and Ribichini, Flavio and García-Blas, Sergio and Dumonteil, Nicolas and Abizaid, Alexandre and Sartori, Samantha and D'Errigo, Paola and Tarantini, Giuseppe and Lunardi, Mattia and Orvin, Katia and Pagnesi, Matteo and Navarro, Felipe and Dangas, George and Mehran, Roxana and Delewi, Ronak},
  title = {Cerebrovascular Events in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation: A Pooled Patient‐Level Study},
  journal = {Journal of the American Heart Association},
  year = {2024},
  doi = {10.1161/jaha.123.032901}
}
Kostenlos starten →